Last Updated: August 11, 2022, 23:22 IST
Biological E. Ltd (BE) on Thursday said it has delivered 10 crores (100 million) doses of its Covid-19 vaccine, Corbevax to the Centre so far and is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday.
The price of Corbevax for private Covid-19 vaccination centers is Rs. 250, inclusive of GST. For the end-user, the price was fixed at Rs 400, including taxes and administrative charges.
In a release, the city-based vaccine maker said, Biological E. Limited has delivered 10 crore doses of Corbevax to the Government of India so far. Pan-India roll-out of Corbevax in children 12-14 years of age was initiated on March 16, 2022, and till now almost seven crore doses have been administered, and 2.9 crore children have completed the two-dose vaccination regimen.”
Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under emergency use authorization for individuals aged 18 years and above after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield, the company said.
The Health Ministry’s approval is based on the recommendations made recently by the Covid-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI).
This approval came after the Drug Controller General of India (DCGI) approved the vaccine for emergency use as a heterologous Covid-19 booster dose for individuals aged 18 years on June 4, 2022. The vaccine had received emergency use authorization as a primary two-dose vaccination regimen in Adults, Adolescents, and Children of five years and above, in a series of approvals from December 2021 to April 2022.